Cancer Detector Device has been developed at the Massachusetts General Hospital in the United States, which has surprised many doctors and technology enthusiasts.
It is a device that can diagnose and detect quickly and accurately tumors and other diseases in areas where previous technologies had never arrived.
the technology was based on a Smartphone that is able to use a technology similar to that used to make graphograms for the purpose of obtaining detailed microscopic images for later analysis of the molecular composition of tissues and cells.
This new technology is known as D3, consists of an LED light that fits with the basic Smartphone battery and can record the images in high quality and resolution with the camera of the phone. The D3 system is capable of registering more than 100,000 cells in a single sample of tissue or blood because it has a greater field of vision than traditional microscopy.
Transmission of the data for analysis is done through a secure service that goes directly to the graphics-encrypted graphics processing server. The results are obtained quickly and are reflected in the point of attention.
When the blood or tissue sample is taken, the molecular analysis of the tumors with microbeads is done; they are united to the molecules related to cancer and are loaded into a module in the D3 that is in charge of forming images.
Once the image is obtained, the data go directly to the server and it is in charge of detecting the presence of specific molecules using the analyzed patterns of diffraction generated by the microbeads.
The different sizes of beads or covers offer different diffraction fingerprints that facilitate the detection of cancer. The numerical algorithm developed by the Massachusetts Hospital engineers of the D3 device can recognize all the beads and analyze up to 10 MB of information in less than nine-hundredths of a second.
Thanks to the number of microspheres labeled with the antibodies that are in the cells, the D3 is able to analyze and classify with precision and rapidity all the samples that are obtained and differentiates them between low risk and high risk or in case they are benign, is also able to identify them, with results that coincide with conventional pathological analyzes.
D3 is able to detect tumors in samples of lymph node biopsies with a thin needle. This device was used to verify that several people had certain tumors in their lymphoma and the results obtained were identical to those found in the study by conventional pathology.
Over time and technological developments, the D3 is expected to improve every day and expand the database to be able to detect all possible types of cancer and also to be accessible to all possible public.
With this device is increasing the technology in Smartphones and is a breakthrough for the world and technologies on the phones. The system must be fast and capable of detecting all the possible risks that can cause cancer, in case there are no tumors. In addition, the cost of conventional pathological services would be reduced.